MedPath

Assessment of Differential Renal Function by CT in Living Donors

Not Applicable
Completed
Conditions
Living Donor of Kidney
Interventions
Other: Differential renal function assessment by 4D CT
Registration Number
NCT02820376
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

The purpose of this study is to assess the degree of agreement of the measurement of differential renal function in living donors by CT (computed tomography) and SPECT (single photon emission computed tomography).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Kidney living donor candidate (approval given) undergoing a morphological and functional renal assessment
  • Mandatory enrollment in a health security plan (French Social Security)
  • Subject having signed an informed consent
Exclusion Criteria
  • Contra-indications to computed tomography with iodinated contrast medium injection, or to scintigraphy
  • Subjects with an abnormal urinary tract (unique kidney, ectopic kidney, horseshoe kidney)
  • Subjets under a legal protection measure

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
All patientsDifferential renal function assessment by 4D CTDifferential renal function assessment by 4D CT: All patients will undergo both CT and SPECT assessment of differential renal function; each patient will be his own comparator
Primary Outcome Measures
NameTimeMethod
degree of agreementthrough study completion (2 years)

Differential renal function (DRF) measured by each technique (CT and SPECT) Regions of interest will be drawn on each kidney and the aorta to obtain time-intensity curves and derive the Patlak plot; the Patlak model will then be used to determine the slope of each kidney and thus to calculate the differential renal function (percentage of each kidney in the total renal function).

Degree of agreement will be assessed by calculating the intra-class correlation coefficient and its 95% confidence interval, and the Bland-Altman plot.

Secondary Outcome Measures
NameTimeMethod
Radiation dose exposure for each technique1 day

Additional radiation dose exposure (CTDIvol and DLP) will be recorded and follow-up

Agreement between post-processing methods for CTthrough study completion (2 years)

Comparison between Patlak-Ruthland method, its modified version and the area under the curve method

Intra- and inter-observer reproducibility of CT DRF measurementthrough study completion (2 years)
Automatic post-processing for Patlak-Ruthland methodthrough study completion (2 years)

Trial Locations

Locations (1)

CHRU Nancy

🇫🇷

Nancy, France

© Copyright 2025. All Rights Reserved by MedPath